Jon Amund Eriksen

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

Stephan Bernhardt, Dagmar S. Trachsel, Mona Møller et al. · British Journal of Cancer · 2006 · 298 citations · Full text

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

Trond Buanes, Arne R. Rosseland, Arne Bakka et al. · International Journal of Cancer · 2001 · 273 citations

Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

Ingvil Sæterdal, Jens Bjørheim, Kari Lislerud et al. · Proceedings of the National Academy of Sciences · 2001 · 266 citations · Full text

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

Paal Brunsvig, Steinar Aamdal, Gunnar Kvalheim et al. · Cancer Immunology Immunotherapy · 2006 · 243 citations · Full text

Telomerase Peptide Vaccination, Cancer Immunosurveillance, Phase I/ii Study +11

Long‐term follow‐up of patients with resected pancreatic cancer following vaccination against mutant K‐ras

Synne Wedén, Marianne Klemp, Ivar P. Gladhaug et al. · International Journal of Cancer · 2010 · 180 citations